Please login to the form below

Not currently logged in
Email:
Password:

Rare disease UK

This page shows the latest Rare disease UK news and features for those working in and with pharma, biotech and healthcare.

Will Shire agree to extend Takeda takeover talks?

Will Shire agree to extend Takeda takeover talks?

Will Shire agree to extend Takeda takeover talks? UK rules mean Shire must agree to extend deadline. ... making a move for the Dublin-domiciled, UK-registered rare disease company.

Latest news

  • GSK hands rare disease assets over to Orchard GSK hands rare disease assets over to Orchard

    GSK hands rare disease assets over to Orchard. The UK pharma group will take a 19.9% stake in its ex-rival. ... GlaxoSmithKline has decided the future of its rare disease business - and it lies outside the company.

  • emotive partners with Rare Disease UK for public awareness campaign emotive partners with Rare Disease UK for public awareness campaign

    emotive partners with Rare Disease UK for public awareness campaign. Will launch the campaign ahead of next month's Rare Disease Day. ... Partnering with emotive, Rare Disease UK hopes that the agency can bring creativity to their campaign.

  • Amicus gets NICE green light for Fabry drug Amicus gets NICE green light for Fabry drug

    The National Institute of Health and Care Excellence has given its blessing to Amicus' oral therapy for Fabry disease, a rare genetic disorder. ... The UK's cost-effectiveness regulator has published final guidance endorsing the use of Galafold

  • Pharma companies back Rare Disease Day Pharma companies back Rare Disease Day

    In the UK, Rare Disease Day 2014 is focusing on the implementation of the UK Strategy for Rare Diseases, launched last November. ... UK staff, in addition to taking part in the torch relay, will submit articles to the national Rare Disease Day supplement.

  • Rare disease strategy for the UK launched Rare disease strategy for the UK launched

    Rare disease strategy for the UK launched. Aims to improve understanding and boost research. ... Rare disease research in the UK. Another key strand to the strategy seeks to position the UK as a world leader in research and development to improve the

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma. ... However, as referring and prescribing doctors in rare disease can be small in number and geographically spread,

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma. ... However, as referring and prescribing doctors in rare disease can be small in

  • A rare talent A rare talent

    As part of his efforts in this area Sebastian chairs the Rare Disease Strategy Group with UK industry body the ABPI. ... Making sense of change. From a newly enlarged company to new premises, to - perhaps - new HTA arrangements for rare disease

  • The distressing impact of rare diseases The distressing impact of rare diseases

    The company, which has a significant stake in the area, conducted online surveys in January among more than 1, 000 US/UK rare disease patients, carers, doctors, payers, government/institution representatives ... A UK patient with mixed connective tissue

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics